குடல் ப்ராஜெக்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குடல் ப்ராஜெக்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குடல் ப்ராஜெக்ட் Today - Breaking & Trending Today

More Support for Gene Assay to Guide Breast Cancer Treatment


email article
Patients with ultralow-risk breast cancer according to genomic assessment had excellent long-term outcomes regardless of clinical risk or whether they received adjuvant therapy, a new analysis of a randomized trial showed.
The 8-year breast cancer-specific survival (BCSS) was 99.2% among patients classified as clinically high-risk but ultralow-risk by the MammaPrint 70-gene assay. Patients with an ultralow-risk genomic assessment and low clinical risk had an 8-year BCSS of 99.7%. Freedom from distant metastasis at 8 years was 97.6% in patients who were clinically and genomically low-risk versus 95.0% for those who were clinically high-risk but genomically low-risk.
In patients with an ultralow-risk genomic assessment, the 8-year distant metastasis-free interval (DMFI) rate was 97.8% with no adjuvant systemic therapy. That compared with an 8-year DMFI of 97.4% in patients who received only adjuvant endocrine therapy and 94.9% in patients who received ....

United States , Noord Holland , Priya Rastogi , Charles Bankhead , Josephine Lopes Cardozo , National Surgical Adjuvant Breast , American Society Of Clinical Oncology , University Of Pittsburgh , Netherlands Cancer Institute , American Society , Clinical Oncology , Surgical Adjuvant Breast , Bowel Project , Medpage Today , Endocrine Therapy , Breast Cancer , ஒன்றுபட்டது மாநிலங்களில் , நூற்த் ஹாலண்ட் , பிரியா ரஸ்டோகி , சார்லஸ் வங்கித் தலை , ஜோசபின் லோப்ஸ் கார்டோசோ , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் , நெதர்லாந்து புற்றுநோய் நிறுவனம் , அமெரிக்கன் சமூகம் , மருத்துவ புற்றுநோயியல் ,

Memorial Health announces new affiliation - Urbana Daily Citizen


Memorial Health announces new affiliation
Submitted story
A new Cancer Center on Memorial’s main campus will improve and enhance the patient experience with communal and private treatment areas featuring natural light and outdoor views.
Submitted photo
MARYSVILLE – Memorial Health is continuing its focus and dedication to the fight against cancer, with a mission to bring advanced oncology and hematology services to area residents. Two recent developments in this mission include a formal affiliation with The James Cancer Network (JCN), as well as the opening of a new Cancer Center on its main campus in Marysville.
Memorial recently announced the organization has teamed up with one of the nation’s leading cancer research and care providers, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), through its James Cancer Network. ....

Plain City , United States , Ohio State University , Memorial Hospital , Jenna Hoffman , Robert Rupert , William Farrar , National Surgical Adjuvant Breast , Ohio State University Comprehensive Cancer Center , Memorial Hospital Outpatient Surgery Center , Memorial City Gate Medical Center , Memorial Urbana Medical Center , Cancer Center On Memorial , James Cancer Network , Ohio State University College Of Medicine , Leukemia Group , Solove Research Institute , Specialty Care Center , Cancer Center , Memorial Medical Group , Memorial Specialty Care Team , Memorial Health , Radiation Therapy Oncology Group , Memorial Health Foundation , James Cancer Hospital , James Cancer ,